BDTX BLACK DIAMOND THERAPEUTICS INC Management Changes 8-K Filing 2024 - Annual Meeting and Amendment Approval Black Diamond Therapeutics held its 2024 Annual Meeting of Stockholders, where stockholders approved an amendment to limit the liability of certain officers of the company.Get access to all SEC 8-K filings of the BLACK DIAMOND THERAPEUTICS INC